Febumac 80 Tablet contains Febuxostat 80mg, a medication primarily used to manage hyperuricemia in patients with gout. Febuxostat works by selectively inhibiting xanthine oxidase, an enzyme responsible for converting purines into uric acid, thereby reducing serum uric acid levels. This reduction helps prevent gout attacks and complications such as joint inflammation and tophi formation. Febumac 80 is typically prescribed for patients who have not responded well to other urate-lowering therapies or those who are intolerant to allopurinol. The tablet is taken orally, usually once daily, with or without food, as directed by a healthcare professional. It is important to maintain adequate hydration during treatment to help prevent kidney stones. Common side effects may include nausea, joint pain, rash, and liver enzyme abnormalities; therefore, regular monitoring of liver function tests is recommended. Febumac 80 should be used cautiously in patients with liver or kidney impairment and is not recommended during pregnancy or breastfeeding. Patients should inform their doctor about any other medications they are taking to avoid potential drug interactions. Overall, Febumac 80 is an effective option for long-term management of gout by controlling uric acid levels and reducing the frequency of acute attacks.